SUMO Modification of DNA topoisomerase II: Trying to get a CENse of it all

DNA Repair

Volumn 8, Issue 4, 2009, Pages 557-568

  Lee, Ming Ta ^a   Bachant, Jeff ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aurora B Ipl1; Centromere; Chromosome dynamics; Chromosome segregation; DNA topoisomerase II; Kinetochore; Mitosis; Spindle assembly checkpoint; SUMO; Sumoylation

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); SUMO PROTEIN;

ANEUPLOIDY; CENTROMERE; CHROMOSOME SEGREGATION; ENZYME METABOLISM; HUMAN; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; SUMOYLATION; YEAST;

AMINO ACID SEQUENCE; ANIMALS; CENTROMERE; CHROMOSOME ABERRATIONS; DNA REPAIR ENZYMES; DNA TOPOISOMERASES, TYPE II; HUMANS; MITOSIS; MOLECULAR SEQUENCE DATA; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; STRESS, PHYSIOLOGICAL;

METAZOA;

EID: 63049138013     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2009.01.004     Document Type: Review

References (189)

1. Dasso M. Emerging roles of the SUMO pathway in mitosis. Cell Div. 3 (2008) 5
2. Li S.J., and Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature 398 (1999) 246-251
3. Zhang X.D., Goeres J., Zhang H., Yen T.J., Porter A.C., and Matunis M.J. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis. Mol. Cell 29 (2008) 729-741
4. Ayaydin F., and Dasso M. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol. Biol. Cell 15 (2004) 5208-5218
5. Seufert W., Futcher B., and Jentsch S. Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373 (1995) 78-81
6. Biggins S., Bhalla N., Chang A., Smith D.L., and Murray A.W. Genes involved in sister chromatid separation and segregation in the budding yeast Saccharomyces cerevisiae. Genetics 159 (2001) 453-470
7. Azuma Y., Arnaoutov A., and Dasso M. SUMO-2/3 regulates topoisomerase II in mitosis. J. Cell Biol. 163 (2003) 477-487
8. Azuma Y., Arnaoutov A., Anan T., and Dasso M. PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes. EMBO J. 24 (2005) 2172-2182
9. Dieckhoff P., Bolte M., Sancak Y., Braus G.H., and Irniger S. Smt3/SUMO and Ubc9 are required for efficient APC/C-mediated proteolysis in budding yeast. Mol. Microbiol. 51 (2004) 1375-1387
10. Diaz-Martinez L.A., Gimenez-Abian J.F., Azuma Y., Guacci V., Gimenez-Martin G., Lanier L.M., and Clarke D.J. PIASgamma is required for faithful chromosome segregation in human cells. PLoS ONE 1 (2006) e53
11. Dawlaty M.M., Malureanu L., Jeganathan K.B., Kao E., Sustmann C., Tahk S., Shuai K., Grosschedl R., and van Deursen J.M. Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell 133 (2008) 103-115
12. Nacerddine K., Lehembre F., Bhaumik M., Artus J., Cohen-Tannoudji M., Babinet C., Pandolfi P.P., and Dejean A. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9 (2005) 769-779
13. Denison C., Rudner A.D., Gerber S.A., Bakalarski C.E., Moazed D., and Gygi S.P. A proteomic strategy for gaining insights into protein sumoylation in yeast. Mol. Cell Proteomics 4 (2005) 246-254
14. Hannich J.T., Lewis A., Kroetz M.B., Li S.J., Heide H., Emili A., and Hochstrasser M. Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J. Biol. Chem. 280 (2005) 4102-4110
15. Panse V.G., Hardeland U., Werner T., Kuster B., and Hurt E. A proteome-wide approach identifies sumoylated substrate proteins in yeast. J. Biol. Chem. 279 (2004) 41346-41351
16. Wohlschlegel J.A., Johnson E.S., Reed S.I., and Yates III J.R. Global analysis of protein sumoylation in Saccharomyces cerevisiae. J. Biol. Chem. 279 (2004) 45662-45668
17. Bachant J., Alcasabas A., Blat Y., Kleckner N., and Elledge S.J. The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Mol. Cell 9 (2002) 1169-1182
18. Champoux J.J. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70 (2001) 369-413
19. Gadelle D., Filee J., Buhler C., and Forterre P. Phylogenomics of type II DNA topoisomerases. Bioessays 25 (2003) 232-242
20. Caron P.R., Watt P., and Wang J.C. The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II. Mol. Cell. Biol. 14 (1994) 3197-3207
21. Shiozaki K., and Yanagida M. Functional dissection of the phosphorylated termini of fission yeast DNA topoisomerase II. J. Cell Biol. 119 (1992) 1023-1036
22. Crenshaw D.G., and Hsieh T. Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophila melanogaster. II. In vivo studies. J. Biol. Chem. 268 (1993) 21335-21343
23. Crenshaw D.G., and Hsieh T. Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophila melanogaster. I. In vitro studies. J. Biol. Chem. 268 (1993) 21328-21334
24. McClendon A.K., Dickey J.S., and Osheroff N. Ability of viral topoisomerase II to discern the handedness of supercoiled DNA: bimodal recognition of DNA geometry by type II enzymes. Biochemistry 45 (2006) 11674-11680
25. Dickey J.S., and Osheroff N. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme. Biochemistry 44 (2005) 11546-11554
26. Cardenas M.E., Dang Q., Glover C.V., and Gasser S.M. Casein kinase II phosphorylates the eukaryote-specific C-terminal domain of topoisomerase II in vivo. EMBO J. 11 (1992) 1785-1796
27. Wells N.J., Addison C.M., Fry A.M., Ganapathi R., and Hickson I.D. Serine 1524 is a major site of phosphorylation on human topoisomerase II alpha protein in vivo and is a substrate for casein kinase II in vitro. J. Biol. Chem. 269 (1994) 29746-29751
28. Daum J.R., and Gorbsky G.J. Casein kinase II catalyzes a mitotic phosphorylation on threonine 1342 of human DNA topoisomerase IIalpha, which is recognized by the 3F3/2 phosphoepitope antibody. J. Biol. Chem. 273 (1998) 30622-30629
29. Escargueil A.E., Plisov S.Y., Filhol O., Cochet C., and Larsen A.K. Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469. J. Biol. Chem. 275 (2000) 34710-34718
30. Li H., Wang Y., and Liu X. Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression. J. Biol. Chem. 283 (2008) 6209-6221
31. Iida M., Matsuda M., and Komatani H. Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1. Biochem. J. 411 (2008) 27-32
32. Morrison C., Henzing A.J., Jensen O.N., Osheroff N., Dodson H., Kandels-Lewis S.E., Adams R.R., and Earnshaw W.C. Proteomic analysis of human metaphase chromosomes reveals topoisomerase II alpha as an Aurora B substrate. Nucleic Acids Res. 30 (2002) 5318-5327
33. Takahashi Y., Yong-Gonzalez V., Kikuchi Y., and Strunnikov A. SIZ1/SIZ2 control of chromosome transmission fidelity is mediated by the sumoylation of topoisomerase II. Genetics 172 (2006) 783-794
34. Chung T.D., Drake F.H., Tan K.B., Per S.R., Crooke S.T., and Mirabelli C.K. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 9431-9435
35. Sakaguchi A., and Kikuchi A. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase. J. Cell Sci. 117 (2004) 1047-1054
36. Akimitsu N., Adachi N., Hirai H., Hossain M.S., Hamamoto H., Kobayashi M., Aratani Y., Koyama H., and Sekimizu K. Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIalpha. Genes Cells 8 (2003) 393-402
37. Yang X., Li W., Prescott E.D., Burden S.J., and Wang J.C. DNA topoisomerase IIbeta and neural development. Science 287 (2000) 131-134
38. Ju B.G., Lunyak V.V., Perissi V., Garcia-Bassets I., Rose D.W., Glass C.K., and Rosenfeld M.G. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312 (2006) 1798-1802
39. Lyu Y.L., Lin C.P., Azarova A.M., Cai L., Wang J.C., and Liu L.F. Role of topoisomerase IIbeta in the expression of developmentally regulated genes. Mol. Cell. Biol. 26 (2006) 7929-7941
40. Berger J.M. Type II DNA topoisomerases. Curr. Opin. Struct. Biol. 8 (1998) 26-32
41. Wang J.C. Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine. Q. Rev. Biophys. 31 (1998) 107-144
42. Salceda J., Fernandez X., and Roca J. Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA. EMBO J. 25 (2006) 2575-2583
43. Liu L.F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58 (1989) 351-375
44. Froelich-Ammon S.J., and Osheroff N. Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem. 270 (1995) 21429-21432
45. McClendon A.K., and Osheroff N. DNA topoisomerase II, genotoxicity, and cancer. Mutat. Res. 623 (2007) 83-97
46. Zucchi R., and Danesi R. Cardiac toxicity of antineoplastic anthracyclines. Curr. Med. Chem. Anticancer Agents 3 (2003) 151-171
47. Lyu Y.L., Kerrigan J.E., Lin C.P., Azarova A.M., Tsai Y.C., Ban Y., and Liu L.F. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res. 67 (2007) 8839-8846
48. Felix C.A. Secondary leukemias induced by topoisomerase-targeted drugs. Biochim. Biophys. Acta 1400 (1998) 233-255
49. Azarova A.M., Lyu Y.L., Lin C.P., Tsai Y.C., Lau J.Y., Wang J.C., and Liu L.F. Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 11014-11019
50. Larsen A.K., Escargueil A.E., and Skladanowski A. Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol. Ther. 99 (2003) 167-181
51. Andoh T., and Ishida R. Catalytic inhibitors of DNA topoisomerase II. Biochim. Biophys. Acta 1400 (1998) 155-171
52. Roca J., Ishida R., Berger J.M., Andoh T., and Wang J.C. Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1781-1785
53. Classen S., Olland S., and Berger J.M. Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10629-10634
54. Germe T., and Hyrien O. Topoisomerase II-DNA complexes trapped by ICRF-193 perturb chromatin structure. EMBO Rep. 6 (2005) 729-735
55. Carpenter A.J., and Porter A.C. Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line. Mol. Biol. Cell 15 (2004) 5700-5711
56. Baxter J., and Diffley J.F. Topoisomerase II inactivation prevents the completion of DNA replication in budding yeast. Mol. Cell 30 (2008) 790-802
57. Sundin O., and Varshavsky A. Arrest of segregation leads to accumulation of highly intertwined catenated dimers: dissection of the final stages of SV40 DNA replication. Cell 25 (1981) 659-669
58. Schvartzman J.B., and Stasiak A. A topological view of the replicon. EMBO Rep. 5 (2004) 256-261
59. Wang J.C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 3 (2002) 430-440
60. Buchenau P., Saumweber H., and Arndt-Jovin D.J. Consequences of topoisomerase II inhibition in early embryogenesis of Drosophila revealed by in vivo confocal laser scanning microscopy. J. Cell Sci. 104 Pt 4 (1993) 1175-1185
61. DiNardo S., Voelkel K., and Sternglanz R. DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 2616-2620
62. Uemura T., and Tanagida M. Mitotic spindle pulls but fails to separate chromosomes in type II DNA topoisomerase mutants: uncoordinated mitosis. EMBO J. 5 (1986) 1003-1010
63. Uemura T., Ohkura H., Adachi Y., Morino K., Shiozaki K., and Yanagida M. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell 50 (1987) 917-925
64. Holm C., Goto T., Wang J.C., and Botstein D. DNA topoisomerase II is required at the time of mitosis in yeast. Cell 41 (1985) 553-563
65. Downes C.S., Mullinger A.M., and Johnson R.T. Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 8895-8899
66. Gorbsky G.J. Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane). Cancer Res. 54 (1994) 1042-1048
67. Shamu C.E., and Murray A.W. Sister chromatid separation in frog egg extracts requires DNA topoisomerase II activity during anaphase. J. Cell Biol. 117 (1992) 921-934
68. Clarke D.J., Johnson R.T., and Downes C.S. Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J. Cell Sci. 105 (1993) 563-569
69. Ishida R., Sato M., Narita T., Utsumi K.R., Nishimoto T., Morita T., Nagata H., and Andoh T. Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J. Cell Biol. 126 (1994) 1341-1351
70. Hardy C.D., Crisona N.J., Stone M.D., and Cozzarelli N.R. Disentangling DNA during replication: a tale of two strands. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359 (2004) 39-47
71. Holm C. Coming undone: how to untangle a chromosome. Cell 77 (1994) 955-957
72. Warburton P.E., and Earnshaw W.C. Untangling the role of DNA topoisomerase II in mitotic chromosome structure and function. Bioessays 19 (1997) 97-99
73. Earnshaw W.C., and Heck M.M. Localization of topoisomerase II in mitotic chromosomes. J. Cell Biol. 100 (1985) 1716-1725
74. Gasser S.M., Laroche T., Falquet J., Boy de la Tour E., and Laemmli U.K. Metaphase chromosome structure. Involvement of topoisomerase II. J. Mol. Biol. 188 (1986) 613-629
75. Taagepera S., Rao P.N., Drake F.H., and Gorbsky G.J. DNA topoisomerase II alpha is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8407-8411
76. Saitoh Y., and Laemmli U.K. Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell 76 (1994) 609-622
77. Sumner A.T. The distribution of topoisomerase II on mammalian chromosomes. Chromosome Res. 4 (1996) 5-14
78. Meyer K.N., Kjeldsen E., Straub T., Knudsen B.R., Hickson I.D., Kikuchi A., Kreipe H., and Boege F. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol. 136 (1997) 775-788
79. Tavormina P.A., Come M.G., Hudson J.R., Mo Y.Y., Beck W.T., and Gorbsky G.J. Rapid exchange of mammalian topoisomerase II alpha at kinetochores and chromosome arms in mitosis. J. Cell Biol. 158 (2002) 23-29
80. Null A.P., Hudson J., and Gorbsky G.J. Both alpha and beta isoforms of mammalian DNA topoisomerase II associate with chromosomes in mitosis. Cell Growth Differ. 13 (2002) 325-333
81. Boy de la Tour E., and Laemmli U.K. The metaphase scaffold is helically folded: sister chromatids have predominantly opposite helical handedness. Cell 55 (1988) 937-944
82. Swedlow J.R., Sedat J.W., and Agard D.A. Multiple chromosomal populations of topoisomerase II detected in vivo by time-lapse, three-dimensional wide-field microscopy. Cell 73 (1993) 97-108
83. Christensen M.O., Larsen M.K., Barthelmes H.U., Hock R., Andersen C.L., Kjeldsen E., Knudsen B.R., Westergaard O., Boege F., and Mielke C. Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells. J. Cell Biol. 157 (2002) 31-44
84. Gimenez-Abian J.F., Clarke D.J., Mullinger A.M., Downes C.S., and Johnson R.T. A postprophase topoisomerase II-dependent chromatid core separation step in the formation of metaphase chromosomes. J. Cell Biol. 131 (1995) 7-17
85. Moens P.B., and Earnshaw W.C. Anti-topoisomerase II recognizes meiotic chromosome cores. Chromosoma 98 (1989) 317-322
86. Cobb J., Miyaike M., Kikuchi A., and Handel M.A. Meiotic events at the centromeric heterochromatin: histone H3 phosphorylation, topoisomerase II alpha localization and chromosome condensation. Chromosoma 108 (1999) 412-425
87. Rattner J.B., Hendzel M.J., Furbee C.S., Muller M.T., and Bazett-Jones D.P. Topoisomerase II alpha is associated with the mammalian centromere in a cell cycle- and species-specific manner and is required for proper centromere/kinetochore structure. J. Cell Biol. 134 (1996) 1097-1107
88. Ishida R., Takashima R., Koujin T., Shibata M., Nozaki N., Seto M., Mori H., Haraguchi T., and Hiraoka Y. Mitotic specific phosphorylation of serine-1212 in human DNA topoisomerase IIalpha. Cell Struct. Funct. 26 (2001) 215-226
89. Swedlow J.R., and Hirano T. The making of the mitotic chromosome: modern insights into classical questions. Mol. Cell 11 (2003) 557-569
90. Belmont A.S. Mitotic chromosome scaffold structure: new approaches to an old controversy. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15855-15857
91. Belmont A.S. Mitotic chromosome structure and condensation. Curr. Opin. Cell Biol. 18 (2006) 632-638
92. Andersen C.L., Wandall A., Kjeldsen E., Mielke C., and Koch J. Active, but not inactive, human centromeres display topoisomerase II activity in vivo. Chromosome Res. 10 (2002) 305-312
93. Agostinho M., Rino J., Braga J., Ferreira F., Steffensen S., and Ferreira J. Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis. Mol. Biol. Cell 15 (2004) 2388-2400
94. Floridia G., Zatterale A., Zuffardi O., and Tyler-Smith C. Mapping of a human centromere onto the DNA by topoisomerase II cleavage. EMBO Rep. 1 (2000) 489-493
95. Spence J.M., Critcher R., Ebersole T.A., Valdivia M.M., Earnshaw W.C., Fukagawa T., and Farr C.J. Co-localization of centromere activity, proteins and topoisomerase II within a subdomain of the major human X alpha-satellite array. EMBO J. 21 (2002) 5269-5280
96. Spence J.M., Fournier R.E., Oshimura M., Regnier V., and Farr C.J. Topoisomerase II cleavage activity within the human D11Z1 and DXZ1 alpha-satellite arrays. Chromosome Res. 13 (2005) 637-648
97. Kallio M., and Lahdetie J. Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposide. Mutagenesis 11 (1996) 435-443
98. Kas E., and Laemmli U.K. In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics. EMBO J. 11 (1992) 705-716
99. Blat Y., and Kleckner N. Cohesins bind to preferential sites along yeast chromosome III, with differential regulation along arms versus the centric region. Cell 98 (1999) 249-259
100. Laloraya S., Guacci V., and Koshland D. Chromosomal addresses of the cohesin component Mcd1p. J. Cell Biol. 151 (2000) 1047-1056
101. Tanaka T., Cosma M.P., Wirth K., and Nasmyth K. Identification of cohesin association sites at centromeres and along chromosome arms. Cell 98 (1999) 847-858
102. Bermejo R., Doksani Y., Capra T., Katou Y.M., Tanaka H., Shirahige K., and Foiani M. Top1- and Top2-mediated topological transitions at replication forks ensure fork progression and stability and prevent DNA damage checkpoint activation. Genes Dev. 21 (2007) 1921-1936
103. Porter A.C., and Farr C.J. Topoisomerase II: untangling its contribution at the centromere. Chromosome Res. 12 (2004) 569-583
104. Baumann C., Korner R., Hofmann K., and Nigg E.A. PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint. Cell 128 (2007) 101-114
105. Chan K.L., North P.S., and Hickson I.D. BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges. EMBO J. 26 (2007) 3397-3409
106. Spence J.M., Phua H.H., Mills W., Carpenter A.J., Porter A.C., and Farr C.J. Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads. J. Cell Sci. 120 (2007) 3952-3964
107. Wang L.H., Schwarzbraun T., Speicher M.R., and Nigg E.A. Persistence of DNA threads in human anaphase cells suggests late completion of sister chromatid decatenation. Chromosoma 117 (2008) 123-135
108. Toyoda Y., and Yanagida M. Coordinated requirements of human topo II and cohesin for metaphase centromere alignment under Mad2-dependent spindle checkpoint surveillance. Mol. Biol. Cell 17 (2006) 2287-2302
109. Skoufias D.A., Lacroix F.B., Andreassen P.R., Wilson L., and Margolis R.L. Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphase. Mol. Cell 15 (2004) 977-990
110. Mikhailov A., Cole R.W., and Rieder C.L. DNA damage during mitosis in human cells delays the metaphase/anaphase transition via the spindle-assembly checkpoint. Curr. Biol. 12 (2002) 1797-1806
111. Iwai M., Hara A., Andoh T., and Ishida R. ICRF-193, a catalytic inhibitor of DNA topoisomerase II, delays the cell cycle progression from metaphase, but not from anaphase to the G1 phase in mammalian cells. FEBS Lett. 406 (1997) 267-270
112. Holm C., Stearns T., and Botstein D. DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. Mol. Cell. Biol. 9 (1989) 159-168
113. Bhalla N., Biggins S., and Murray A.W. Mutation of YCS4, a budding yeast condensin subunit, affects mitotic and nonmitotic chromosome behavior. Mol. Biol. Cell 13 (2002) 632-645
114. Murray A.W., and Szostak J.W. Chromosome segregation in mitosis and meiosis. Annu. Rev. Cell Biol. 1 (1985) 289-315
115. Diaz-Martinez L.A., Gimenez-Abian J.F., and Clarke D.J. Chromosome cohesion-rings, knots, orcs and fellowship. J. Cell Sci. 121 (2008) 2107-2114
116. Dewar H., Tanaka K., Nasmyth K., and Tanaka T.U. Tension between two kinetochores suffices for their bi-orientation on the mitotic spindle. Nature 428 (2004) 93-97
117. Vagnarelli P., Morrison C., Dodson H., Sonoda E., Takeda S., and Earnshaw W.C. Analysis of Scc1-deficient cells defines a key metaphase role of vertebrate cohesin in linking sister kinetochores. EMBO Rep. 5 (2004) 167-171
118. Ruchaud S., Carmena M., and Earnshaw W.C. Chromosomal passengers: conducting cell division. Nat. Rev. Mol. Cell Biol. 8 (2007) 798-812
119. Pinsky B.A., and Biggins S. The spindle checkpoint: tension versus attachment. Trends Cell Biol. 15 (2005) 486-493
120. Gimenez-Abian J.F., Clarke D.J., Gimenez-Martin G., Weingartner M., Gimenez-Abian M.I., Carballo J.A., Diaz de la Espina S.M., Bogre L., and De la Torre C. DNA catenations that link sister chromatids until the onset of anaphase are maintained by a checkpoint mechanism. Eur. J. Cell Biol. 81 (2002) 9-16
121. Diaz-Martinez L.A., Gimenez-Abian J.F., and Clarke D.J. Cohesin is dispensable for centromere cohesion in human cells. PLoS ONE 2 (2007) e318
122. Stanvitch G., and Moore L.L. cin-4, a gene with homology to topoisomerase II, is required for centromere resolution by cohesin removal from sister kinetochores during mitosis. Genetics 178 (2008) 83-97
123. Aguilar C., Davidson C., Dix M., Stead K., Zheng K., Hartman T., and Guacci V. Topoisomerase II suppresses the temperature sensitivity of Saccharomyces cerevisiae pds5 mutants, but not the defect in sister chromatid cohesion. Cell Cycle 4 (2005) 1294-1304
124. Hartman T., Stead K., Koshland D., and Guacci V. Pds5p is an essential chromosomal protein required for both sister chromatid cohesion and condensation in Saccharomyces cerevisiae. J. Cell Biol. 151 (2000) 613-626
125. Kireeva N., Lakonishok M., Kireev I., Hirano T., and Belmont A.S. Visualization of early chromosome condensation: a hierarchical folding, axial glue model of chromosome structure. J. Cell Biol. 166 (2004) 775-785
126. Warsi T.H., Navarro M.S., and Bachant J. DNA topoisomerase II is a determinant of the tensile properties of yeast centromeric chromatin and the tension checkpoint. Mol. Biol. Cell 19 (2008) 4421-4433
127. He X., Asthana S., and Sorger P.K. Transient sister chromatid separation and elastic deformation of chromosomes during mitosis in budding yeast. Cell 101 (2000) 763-775
128. Pearson C.G., Maddox P.S., Salmon E.D., and Bloom K. Budding yeast chromosome structure and dynamics during mitosis. J. Cell Biol. 152 (2001) 1255-1266
129. Coelho P.A., Queiroz-Machado J., Carmo A.M., Moutinho-Pereira S., Maiato H., and Sunkel C.E. Dual role of topoisomerase II in centromere resolution and aurora B activity. PLoS Biol. 6 (2008) e207
130. Loncarek J., Kisurina-Evgenieva O., Vinogradova T., Hergert P., La Terra S., Kapoor T.M., and Khodjakov A. The centromere geometry essential for keeping mitosis error free is controlled by spindle forces. Nature 450 (2007) 745-749
131. Chang C.J., Goulding S., Earnshaw W.C., and Carmena M. RNAi analysis reveals an unexpected role for topoisomerase II in chromosome arm congression to a metaphase plate. J. Cell Sci. 116 (2003) 4715-4726
132. Haraguchi T., Kaneda T., and Hiraoka Y. Dynamics of chromosomes and microtubules visualized by multiple-wavelength fluorescence imaging in living mammalian cells: effects of mitotic inhibitors on cell cycle progression. Genes Cells 2 (1997) 369-380
133. Clarke D.J., Vas A.C., Andrews C.A., Diaz-Martinez L.A., and Gimenez-Abian J.F. Topoisomerase II checkpoints: universal mechanisms that regulate mitosis. Cell Cycle 5 (2006) 1925-1928
134. Wang L., and Eastmond D.A. Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187. Environ. Mol. Mutagen. 39 (2002) 348-356
135. Hajji N., Pastor N., Mateos S., Dominguez I., and Cortes F. DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193. Mutat. Res. 530 (2003) 35-46
136. Park I., and Avraham H.K. Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1. Exp. Cell Res. 312 (2006) 1996-2008
137. Huang K.C., Gao H., Yamasaki E.F., Grabowski D.R., Liu S., Shen L.L., Chan K.K., Ganapathi R., and Snapka R.M. Topoisomerase II poisoning by ICRF-193. J. Biol. Chem. 276 (2001) 44488-44494
138. Downes C.S., Clarke D.J., Mullinger A.M., Gimenez-Abian J.F., Creighton A.M., and Johnson R.T. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372 (1994) 467-470
139. Gimenez-Abian J.F., Weingartner M., Binarova P., Clarke D.J., Anthony R.G., Calderini O., Heberle-Bors E., Diaz de la Espina S.M., Bogre L., and De la Torre C. A topoisomerase II-dependent checkpoint in G2-phase plant cells can be bypassed by ectopic expression of mitotic cyclin B2. Cell Cycle 1 (2002) 187-192
140. Deming P.B., Cistulli C.A., Zhao H., Graves P.R., Piwnica-Worms H., Paules R.S., Downes C.S., and Kaufmann W.K. The human decatenation checkpoint. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12044-12049
141. Deming P.B., Flores K.G., Downes C.S., Paules R.S., and Kaufmann W.K. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase. J. Biol. Chem. 277 (2002) 36832-36838
142. Kaufmann W.K., Campbell C.B., Simpson D.A., Deming P.B., Filatov L., Galloway D.A., Zhao X.J., Creighton A.M., and Downes C.S. Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization. Cell Cycle 1 (2002) 210-219
143. Mikhailov A., Shinohara M., and Rieder C.L. Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. J. Cell Biol. 166 (2004) 517-526
144. Skoufias D.A., Andreassen P.R., Lacroix F.B., Wilson L., and Margolis R.L. Mammalian Mad2 and Bub1/BubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 4492-4497
145. Shannon K.B., Canman J.C., and Salmon E.D. Mad2 and BubR1 function in a single checkpoint pathway that responds to a loss of tension. Mol. Biol. Cell 13 (2002) 3706-3719
146. Taylor S.S., Hussein D., Wang Y., Elderkin S., and Morrow C.J. Kinetochore localisation and phosphorylation of the mitotic checkpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells. J. Cell Sci. 114 (2001) 4385-4395
147. Andrews C.A., Vas A.C., Meier B., Gimenez-Abian J.F., Diaz-Martinez L.A., Green J., Erickson S.L., Vanderwaal K.E., Hsu W.S., and Clarke D.J. A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin. Genes Dev. 20 (2006) 1162-1174
148. Clarke D.J., and Bachant J. Kinetochore structure and spindle assembly checkpoint signaling in the budding yeast, Saccharomyces cerevisiae. Front. Biosci. 13 (2008) 6787-6819
149. Mao Y., Desai S.D., and Liu L.F. SUMO-1 conjugation to human DNA topoisomerase II isozymes. J. Biol. Chem. 275 (2000) 26066-26073
150. Mao Y., Sun M., Desai S.D., and Liu L.F. SUMO-1 conjugation to topoisomerase I: a possible repair response to topoisomerase-mediated DNA damage. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4046-4051
151. Desai S.D., Liu L.F., Vazquez-Abad D., and D'Arpa P. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin. J. Biol. Chem. 272 (1997) 24159-24164
152. Mo Y.Y., Yu Y., Shen Z., and Beck W.T. Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein. J. Biol. Chem. 277 (2002) 2958-2964
153. Desai S.D., Li T.K., Rodriguez-Bauman A., Rubin E.H., and Liu L.F. Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells. Cancer Res. 61 (2001) 5926-5932
154. Saitoh H., and Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275 (2000) 6252-6258
155. Mao Y., Desai S.D., Ting C.Y., Hwang J., and Liu L.F. 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. J. Biol. Chem. 276 (2001) 40652-40658
156. Rallabhandi P., Hashimoto K., Mo Y.Y., Beck W.T., Moitra P.K., and D'Arpa P. Sumoylation of topoisomerase I is involved in its partitioning between nucleoli and nucleoplasm and its clearing from nucleoli in response to camptothecin. J. Biol. Chem. 277 (2002) 40020-40026
157. Christensen M.O., Krokowski R.M., Barthelmes H.U., Hock R., Boege F., and Mielke C. Distinct effects of topoisomerase I and RNA polymerase I inhibitors suggest a dual mechanism of nucleolar/nucleoplasmic partitioning of topoisomerase I. J. Biol. Chem. 279 (2004) 21873-21882
158. Horie K., Tomida A., Sugimoto Y., Yasugi T., Yoshikawa H., Taketani Y., and Tsuruo T. SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin. Oncogene 21 (2002) 7913-7922
159. Haluska Jr. P., Saleem A., Rasheed Z., Ahmed F., Su E.W., Liu L.F., and Rubin E.H. Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein. Nucleic Acids Res. 27 (1999) 2538-2544
160. Hammer E., Heilbronn R., and Weger S. The E3 ligase Topors induces the accumulation of polysumoylated forms of DNA topoisomerase I in vitro and in vivo. FEBS Lett. 581 (2007) 5418-5424
161. Chen X.L., Silver H.R., Xiong L., Belichenko I., Adegite C., and Johnson E.S. Topoisomerase I-dependent viability loss in Saccharomyces cerevisiae mutants defective in both SUMO conjugation and DNA repair. Genetics 177 (2007) 17-30
162. Jacquiau H.R., van Waardenburg R.C., Reid R.J., Woo M.H., Guo H., Johnson E.S., and Bjornsti M.A. Defects in SUMO (small ubiquitin-related modifier) conjugation and deconjugation alter cell sensitivity to DNA topoisomerase I-induced DNA damage. J. Biol. Chem. 280 (2005) 23566-23575
163. Mo Y.Y., Yu Y., Ee P.L., and Beck W.T. Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs. Cancer Res. 64 (2004) 2793-2798
164. Isik S., Sano K., Tsutsui K., Seki M., Enomoto T., Saitoh H., and Tsutsui K. The SUMO pathway is required for selective degradation of DNA topoisomerase IIbeta induced by a catalytic inhibitor ICRF-193(1). FEBS Lett. 546 (2003) 374-378
165. Huang R.Y., Kowalski D., Minderman H., Gandhi N., and Johnson E.S. Small ubiquitin-related modifier pathway is a major determinant of doxorubicin cytotoxicity in Saccharomyces cerevisiae. Cancer Res. 67 (2007) 765-772
166. Desai S.D., Zhang H., Rodriguez-Bauman A., Yang J.M., Wu X., Gounder M.K., Rubin E.H., and Liu L.F. Transcription-dependent degradation of topoisomerase I-DNA covalent complexes. Mol. Cell. Biol. 23 (2003) 2341-2350
167. Wu J., and Liu L.F. Processing of topoisomerase I cleavable complexes into DNA damage by transcription. Nucleic Acids Res. 25 (1997) 4181-4186
168. Xiao H., Mao Y., Desai S.D., Zhou N., Ting C.Y., Hwang J., and Liu L.F. The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3239-3244
169. Zhang A., Lyu Y.L., Lin C.P., Zhou N., Azarova A.M., Wood L.M., and Liu L.F. A protease pathway for the repair of topoisomerase II-DNA covalent complexes. J. Biol. Chem. 281 (2006) 35997-36003
170. Lin C.P., Ban Y., Lyu Y.L., Desai S.D., and Liu L.F. A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes. J. Biol. Chem. 283 (2008) 21074-21083
171. Agostinho M., Santos V., Ferreira F., Costa R., Cardoso J., Pinheiro I., Rino J., Jaffray E., Hay R.T., and Ferreira J. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity. Cancer Res. 68 (2008) 2409-2418
172. Pichler A., Gast A., Seeler J.S., Dejean A., and Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108 (2002) 109-120
173. Joseph J., Liu S.T., Jablonski S.A., Yen T.J., and Dasso M. The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore interactions in vivo. Curr. Biol. 14 (2004) 611-617
174. Wu J., Matunis M.J., Kraemer D., Blobel G., and Coutavas E. Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. J. Biol. Chem. 270 (1995) 14209-14213
175. Wong K.A., Kim R., Christofk H., Gao J., Lawson G., and Wu H. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life. Mol. Cell. Biol. 24 (2004) 5577-5586
176. Roth W., Sustmann C., Kieslinger M., Gilmozzi A., Irmer D., Kremmer E., Turck C., and Grosschedl R. PIASy-deficient mice display modest defects in IFN and Wnt signaling. J. Immunol. 173 (2004) 6189-6199
177. Takahashi Y., and Strunnikov A. In vivo modeling of polysumoylation uncovers targeting of Topoisomerase II to the nucleolus via optimal level of SUMO modification. Chromosoma (2007)
178. Hardeland U., Steinacher R., Jiricny J., and Schar P. Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J. 21 (2002) 1456-1464
179. Song J., Durrin L.K., Wilkinson T.A., Krontiris T.G., and Chen Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14373-14378
180. Lindsley J.E., and Wang J.C. Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10485-10489
181. Shiozaki K., and Yanagida M. A functional 125-kDa core polypeptide of fission yeast DNA topoisomerase II. Mol. Cell. Biol. 11 (1991) 6093-6102
182. Austin C.A., Marsh K.L., Wasserman R.A., Willmore E., Sayer P.J., Wang J.C., and Fisher L.M. Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II beta. J. Biol. Chem. 270 (1995) 15739-15746
183. Meczes E.L., Gilroy K.L., West K.L., and Austin C.A. The impact of the human DNA topoisomerase II C-terminal domain on activity. PLoS ONE 3 (2008) e1754
184. Johnson E.S., and Blobel G. Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J Cell Biol. 147 (1999) 981-994
185. Sampson D.A., Wang M., and Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276 (2001) 21664-21669
186. Ivanov A.V., Peng H., Yurchenko V., Yap K.L., Negorev D.G., Schultz D.C., Psulkowski E., Fredericks W.J., White D.E., Maul G.G., et al. PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol. Cell 28 (2007) 823-837
187. Yeh E., Haase J., Paliulis L.V., Joglekar A., Bond L., Bouck D., Salmon E.D., and Bloom K.S. Pericentric chromatin is organized into an intramolecular loop in mitosis. Curr. Biol. 18 (2008) 81-90
188. Straight A.F., Belmont A.S., Robinett C.C., and Murray A.W. GFP tagging of budding yeast chromosomes reveals that protein-protein interactions can mediate sister chromatid cohesion. Curr. Biol. 6 (1996) 1599-1608
189. Bachant J. InCytes. Mol. Biol. Cell 19 (2008) 4019